Top of the morning to you. And a fine one it is. We may be scurrying about to deposit assorted short people at their respective schoolhouses, but the sun is shiny and the air is crisp. All of which lifts our spirits. This calls for a toast, of course. So join us for that cup of mandatory stimulation as you brace yourself for that growing list of meetings and deadlines and who-knows-what-else. To get you going, here are some tidbits. Have a good one and drop us a line if you hear of anything interesting...
Biomet Offers $280M For DePuy Trauma Business (Reuters)
Three Medco Execs Are Headed To Express Scripts (St. Louis Business Journal)
J&J Alzheimer's Med Cut Chemical Tied To Brain Tangles (Bloomberg News)
AstraZeneca And Amgen Sign Development Pact (Pharma Times)
Bayer Drug Fought GI Tumors In Study (Bloomberg News)
Uncertainly Looms Over Keryx And Aerterna Cancer Drug (Reuters)
Illumina Rejects Roche Bid (Bloomberg News)
South Korean Drugmakers Go To Court Over Price Cuts (Pharma Times)
Bayer Loses Bid To Bar Class-Action In Sex-Bias Suit (Bloomberg News)
Novartis Selects Turkey As HQ For Central Asia (inPharm)
Novo Nordisk To Proceed With Once-Daily Diabetes Shot (Bloomberg News)
Forest Labs Buy Blood Pressure Drug From J&J (Dow Jones)
EDITOR'S NOTE: Please check this post for updates throughout the morning